Pneumonia: Pathophysiology, Lung Injury Mechanisms, Symptoms, Diagnosis, and Evidence-Based Treatment Strategies

Pneumonia is an acute inflammatory infection of the pulmonary parenchyma—airspaces and interstitium—resulting in impaired gas exchange, tissue injury, and systemic responses. It is clinically defined by new infiltrates on chest imaging plus symptoms consistent with lower respiratory tract infection, such as cough, fever, dyspnea, and pleuritic chest pain. Pneumonia can be community-acquired or hospital-acquired, and it may be caused by bacteria, viruses, or fungi. The condition ranges from mild illness that resolves with outpatient care to severe disease with respiratory failure and sepsis.

At the mechanistic level, pneumonia begins when pathogens reach the lower respiratory tract through inhalation, aspiration of oropharyngeal contents, or hematogenous spread. In susceptible hosts, pathogens evade innate defenses: mucociliary clearance is impaired, alveolar macrophage phagocytosis is overwhelmed, and epithelial barriers become dysfunctional. Viral infections can alter host antiviral responses and increase epithelial permeability, creating a milieu for secondary bacterial infection. Once microbial products engage pattern recognition receptors (e.g., Toll-like receptors) on airway epithelial cells and immune cells, a cascade of cytokines and chemokines recruits neutrophils and monocytes.

The resulting lung injury follows a recognizable sequence. Exudation of protein-rich fluid and inflammatory cells into alveoli impairs ventilation. Gas exchange deteriorates because alveolar spaces are consolidated or filled with edema and inflammatory exudate, producing intrapulmonary shunt and ventilation-perfusion mismatch. Hypoxemia may be refractory to supplemental oxygen in severe cases due to diffuse alveolar damage. Inflammatory mediators also contribute to systemic illness: fever reflects hypothalamic cytokine signaling, while elevated acute-phase reactants and leukocytosis indicate a whole-body response. If infection triggers dysregulated host immunity, endothelial dysfunction, coagulation activation, and mitochondrial stress can progress to sepsis.

Clinically, typical pneumonia presents with cough, fever, purulent sputum, and focal chest findings such as crackles or bronchial breath sounds. However, presentation varies with age and comorbidity. Older adults may present with confusion or delirium rather than classic fever. Immunocompromised patients may have attenuated symptoms but more severe radiographic disease. Aspiration-related pneumonia often follows altered consciousness, dysphagia, or intoxication and may involve dependent lobes.

Complications illustrate what pneumonia does to the body beyond the lungs. Parapneumonic effusion can occur when inflammation extends to the pleural space; empyema develops when pleural fluid becomes infected and requires drainage. Necrotizing pneumonia may occur with certain bacterial pathogens and reflects extensive tissue destruction. Destructive processes can lead to cavitation. Severe pneumonia can precipitate acute respiratory distress syndrome (ARDS), characterized by diffuse alveolar-capillary damage, refractory hypoxemia, and diffuse radiographic opacities.

Diagnosis relies on integrating clinical assessment with objective testing. Chest radiography remains a common first-line tool to confirm infiltrates, though computed tomography can detect early disease, complications, or alternative diagnoses. Sputum Gram stain and culture may guide therapy in selected patients, particularly those with severe illness, treatment failure, or comorbid risks. Blood cultures are typically reserved for severe pneumonia, immunocompromised status, or hypotension. Rapid antigen tests or PCR assays can identify viral pathogens such as influenza and respiratory syncytial virus, which informs antiviral use and infection control. Biomarkers like procalcitonin may assist antibiotic stewardship in appropriate contexts.

Treatment is guided by pathogen likelihood, severity, and local resistance patterns. Community-acquired bacterial pneumonia often requires empiric antibiotics targeting common organisms such as Streptococcus pneumoniae, with regimen adjustments based on comorbidities and risk factors for resistant pathogens. Viral pneumonia management focuses on supportive care, with antivirals considered for specific viruses (e.g., influenza) and in high-risk patients. Oxygen therapy, bronchodilators when indicated, and careful fluid management are central to supportive care. In severe cases, hospitalization enables closer monitoring, respiratory support, and evaluation for complications.

Prevention reduces incidence and downstream harm. Vaccination against influenza and pneumococcal disease lowers risk of bacterial pneumonia and complications. Smoking cessation and optimizing chronic disease control improve mucociliary function and immune competence. For aspiration risk, interventions include swallow evaluation, diet modification, posture strategies, and treatment of underlying neurologic disorders.

Recovery depends on pathogen, host factors, and timely therapy. Radiographic clearing may lag behind symptom improvement, especially in older adults or severe disease. Persistent cough or fatigue can occur, but worsening dyspnea, persistent fever, or failure to improve should prompt reassessment for complications, resistant infection, or alternative diagnoses.

Source: @_Healthyorg